Risk of pneumonia with inhaled corticosteroid/long-acting β2 agonist therapy in chronic obstructive pulmonary disease: a cluster analysis

Risk of pneumonia with inhaled corticosteroid/long-acting β2 agonist therapy in chronic obstructive pulmonary disease: a cluster analysis

Rachael L DiSantostefano,1 Hao Li,1 David Hinds,1 Dmitry V Galkin,2 David B Rubin21Worldwide Epidemiology, 2Respiratory Clinical Development, GlaxoSmithKline, Research Triangle Park, Durham, NC, USABackground: Pneumonia poses a significant risk in patients with moderate to severe chronic obstructive...

Full description

Bibliographic Details
Main Authors: DiSantostefano RL, Li H, Hinds D, Galkin DV, Rubin DB
Format: Article
Language:English
Published: Dove Medical Press 2014-05-01
Series:International Journal of COPD
Online Access:http://www.dovepress.com/risk-of-pneumonia-with-inhaled-corticosteroidlong-acting-beta2-agonist-a16714

Internet

http://www.dovepress.com/risk-of-pneumonia-with-inhaled-corticosteroidlong-acting-beta2-agonist-a16714

Similar Items